przewaquinone d has been researched along with pentamidine in 1 studies
*Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. [MeSH]
*Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. [MeSH]
| Studies (przewaquinone d) | Trials (przewaquinone d) | Recent Studies (post-2010) (przewaquinone d) | Studies (pentamidine) | Trials (pentamidine) | Recent Studies (post-2010) (pentamidine) |
|---|---|---|---|---|---|
| 5 | 0 | 3 | 2,411 | 136 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, D; Mukherjee, A; Talukdar, A | 1 |
1 other study(ies) available for przewaquinone d and pentamidine
| Article | Year |
|---|---|
Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside Analogues.
Topics: Animals; Binding Sites; Cell Line, Tumor; Clinical Trials as Topic; Enzyme Inhibitors; Humans; Protein Binding; Protein-Arginine N-Methyltransferases; S-Adenosylmethionine | 2022 |